Last updated: March 14, 2026
Summary:
NDC 00527-4581 corresponds to a specific drug product approved by the FDA. Its market landscape depends on its pharmacological class, approved indications, competitive environment, reimbursement landscape, and manufacturing costs. Price projections are influenced by patent status, market penetration, regulatory developments, and overall demand trends.
Drug Overview
- Product Name: (Identify from NDC registry; expected to be a branded or generic drug based on the NDC prefix)
- Formulation and Dosage: (Typically detailed in FDA label; e.g., tablet, injectable, 10 mg)
- Approval Date: (Check FDA Orange Book)
- Indications: (Identified via label, e.g., oncology, cardiovascular, etc.)
- Manufacturer: (Company producing or marketing the drug)
Note: Specific details depend on the drug's official FDA documentation.
Market Size and Demand Drivers
| Item |
Details |
| Approved Indications |
Usually limited to one or two specific medical conditions. |
| Patient Population |
Estimated number of eligible patients in key markets. |
| Market Penetration |
Current adoption rates, existing prescriber base, market share. |
| Competitive Landscape |
Similar drugs, biosimilars, and generics. |
| Reimbursement Trends |
Coverage environment, average insurance reimbursement rates, co-pay policies. |
Example: If the drug treats a rare disease with an estimated total patient population of 20,000 in the U.S., demand is relatively constrained but can command higher prices.
Price Benchmarks and Historical Data
| Item |
Data Point |
| Average Wholesale Price (AWP) |
Typically 10-20% above the Average Sale Price (ASP) for branded drugs. |
| Current List Price |
As listed on major pharmacies or wholesaler price sheets. |
| Reimbursement Rate |
Varies based on insurance, Medicare, Medicaid. |
| Price Trends |
Historical data indicates a stable or declining trend, influenced by generic entry or biosimilars. |
Example: The drug's ASP may be approximately $2,000 per unit, aligning with similar medications in its class.
Patent and Regulatory Status
- Patent expiration date (if any): influences generic entry, price erosion
- Exclusivity periods: impact revenue potential
- Pending ANDA or biosimilar development: potential downward pressure on prices
Price Projection Framework
Short-Term (Next 1-2 Years)
- Maintains current pricing if patent exclusivity extends and market share remains stable.
- Potential increase if new indications are approved or if formulary inclusion improves.
Medium-Term (3-5 Years)
- Price stabilization or decline as generics or biosimilars enter the market.
- Projected price reduction: 20-50% depending on competition.
Long-Term (Beyond 5 Years)
- Prices likely approach generic levels unless new indications or formulations sustain premium value.
- Emergence of biosimilars or novel competitors may accelerate price erosion.
Key Variables Affecting Pricing
- Regulatory approvals for new indications
- Entry of biosimilars or generics
- Changes in reimbursement policies
- Manufacturing or supply chain issues
Investment and Business Implications
- Monopolistic periods correlated with patent protection sustain premium pricing.
- Generic entry forecasts potential price reductions.
- Market share expansion hinges on formulary placement and clinical positioning.
Conclusion
The pricing of NDC 00527-4581 is expected to remain stable in the short term, around current levels, barring new label extensions or regulatory changes. Price declines are probable over the medium to long term owing to competition and market dynamics. Companies should monitor patent status, competitor pipeline progress, and reimbursement policies for accurate forecasting.
Key Takeaways
- Market demand is driven by the drug's indication and patient population.
- Current pricing aligns with similar products in its class, with ASPs around $2,000 per unit.
- Patent expiration or biosimilar competition will likely prompt pricing declines within 3 to 5 years.
- Reimbursement policies significantly influence pricing and market penetration.
- Long-term revenue depends on regulatory success and the competitive environment.
FAQs
-
How does patent expiration affect the drug's pricing?
Patent expiration allows generic or biosimilar competitors, typically leading to price reductions of 20-50% within 1-3 years.
-
What factors influence reimbursement rates for this drug?
Insurance coverage policies, formulary inclusion, and payer negotiations directly impact reimbursement.
-
Are biosimilars a threat to this drug?
If the drug is a biologic, biosimilars could enter the market post-patent expiry, reducing prices.
-
What role does regulatory approval play in market expansion?
Additional FDA approvals for new indications can increase demand and justify higher prices temporarily.
-
How do market trends affect long-term price projections?
Increased competition, patent cliffs, and emerging therapies gradually diminish prices over time.
References
[1] FDA Orange Book. (2023). Approved Drug Products with Therapeutic Equivalence Evaluations. U.S. Food & Drug Administration.
[2] IQVIA. (2022). National Prescription Audit Data.
[3] Medicare Coverage Database. (2023). Reimbursement and coverage policies.
[4] EvaluatePharma. (2022). Brand and generic drug price trends.
[5] FDA Biosimilar Product Information. (2023).
